查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
器官移植診斷市場 - 2017-2027年全球行業規模、佔有率、趨勢、機會和預測，按組件、移植類型、技術、應用、終端用戶、公司和地區分類
市場調查報告書
商品編碼
1289654

器官移植診斷市場 - 2017-2027年全球行業規模、佔有率、趨勢、機會和預測，按組件、移植類型、技術、應用、終端用戶、公司和地區分類

Organ Transplant Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Component, By Transplant Type, By Technology, By Application, By End User, By company and By Region
出版日期: | 出版商: TechSci Research | 英文 111 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

在2023-2027年的預測期內，全球器官移植診斷市場預計將出現令人矚目的成長。主要因素包括慢性疾病的日益流行，器官移植手術數量的增加，以及在移植診斷領域採用先進技術，這些都推動了市場的成長。器官移植是一種醫療技術，將一個器官從一個人的身體裡取出來，放在接受者的身體裡，以替代受損或缺失的器官。支持市場成長的其他因素包括：政府不斷提高宣傳力度，老年人口不斷增加，器官衰竭的發病率不斷上升，對分子診斷測試的需求很高，對醫療和診斷的投資和支出不斷增加，器官移植手術的數量不斷增加，器官移植診斷項目和新產品開發的不斷推出，以及研究和開發活動的增加。

慢性疾病發病率的上升

全球範圍內慢性疾病，如糖尿病、心血管疾病和其他疾病的發生率不斷上升，促進了市場的成長。這是由於慢性病患者中器官衰竭的風險增加。根據世界衛生組織的數據，心血管疾病（CVDs）是全球死亡的主要原因，每年約有1790萬人死亡。另外，老年人口更容易出現器官故障，特別是肝臟、心臟和腎臟，因此，反過來推動了市場的成長。根據美國政府關於器官捐贈和移植的資訊，在2019年，63%的器官移植者是50歲或以上的人，21%的整體器官移植者是65歲及以上。

意識的提高和器官移植手術數量的增加

在過去的幾年裡，人們對器官移植的認知在不斷提高，這也促進了市場的成長。由於大眾的認知，人們開始進行器官移植手術，這也推動了市場的成長。政府和非政府組織採取了各種計劃，讓人們了解器官移植。此外，器官移植手術數量的增加也推動了市場的成長。由於器官衰竭患者數量的增加，對移植手術的需求也在上升，這促進了市場的成長。根據衛生資源和服務管理局的數據，在2019年，美國約有112,568人需要器官移植。

可用的定製服務

利用給定的市場數據，TechSci Research根據公司的具體需求提供定製服務。該報告可提供以下定製選項：

公司資訊

  • 其他市場參與者（最多5家）的詳細分析和概況。

目錄

第一章：產品概述

第二章：研究方法

第三章：執行摘要

第四章：COVID-19對全球器官移植診斷市場的影響

第五章：客戶的聲音

第六章：全球器官移植診斷市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率與預測
    • 按組成部分（試劑盒和檢測方法、消耗品、服務）分類
    • 按移植類型（實體器官移植與幹細胞移植）分類
    • 按技術分類（分子技術、血清學、流式細胞儀、其他）
    • 按應用（臨床診斷和/或轉化研究）
    • 按終端用戶（醫院和移植中心，學術和研究機構，其他）
    • 按公司分類(2021年)
    • 按地區分類
  • 市場地圖

第七章：北美器官移植診斷市場展望

  • 市場規模和預測
    • 按價值分類
  • 市場佔有率與預測
    • 按元件分類
    • 按移植類型
    • 按技術分類
    • 按應用分類
    • 按終端用戶分類
    • 按國家分類
  • 北美洲：國家分析
    • 美國
    • 美國
    • 墨西哥

第8章：歐洲器官移植診斷市場前景

  • 市場規模和預測
    • 按價值
  • 市場佔有率與預測
    • 按元件分類
    • 按移植類型
    • 按技術分類
    • 按應用分類
    • 按終端用戶分類
    • 按國家分類
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第九章：亞太地區器官移植診斷市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率與預測
    • 按元件分類
    • 按移植類型
    • 按技術分類
    • 按應用分類
    • 按終端用戶分類
    • 按國家分類
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第十章：南美器官移植診斷市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率與預測
    • 按元件分類
    • 按移植類型
    • 按技術分類
    • 按應用分類
    • 按終端用戶分類
    • 按國家分類
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第11章：中東和非洲器官移植診斷市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按元件分類
    • 按移植類型
    • 按技術分類
    • 按應用分類
    • 按終端用戶分類
    • 按國家分類
  • MEA: 國家分析
    • 南非器官移植診斷法
    • 沙烏地阿拉伯器官移植診斷法
    • 阿拉伯聯合大公國器官移植診斷法
    • 土耳其器官移植診斷法
    • 埃及器官移植診斷法

第十二章：市場動態

  • 驅動力
  • 挑戰

第十三章：市場趨勢與發展

第十四章：競爭格局

  • Illumina, Inc.
  • Thermo Fischer Scientific, Inc.
  • Abbott Laboratories, Inc.
  • Quest Diagnostics, Inc.
  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories, Inc.
  • Laboratory Corporation of America Holdings
  • bioMerieux S.A.
  • CareDx, Inc
  • Immucor, Inc.

第十五章：戰略建議

簡介目錄
Product Code: 13069

The global organ transplant diagnostics market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include the growing prevalence of chronic diseases, the increase in the number of organ transplantation surgeries, and the adoption of advanced technology in the field of transplant diagnostics, which are impelling the growth of the market. Organ transplantation is a medical technique in which an organ is removed from one body and placed in a recipient's body to substitute a damaged or missing organ. The other factors supporting the market's growth are, increasing government initiatives for spreading awareness, the rising geriatric population, the rising incidence of organ failure, high demand for molecular diagnostic tests, the surging investment and expenditure in healthcare and diagnostics, growing number of the organ transplant procedure, growing launch of programs & new product development in organ transplant diagnosis, and rise in research and development activities.

Rising Incidences of Chronic diseases

The increasing occurrence of chronic diseases, such as diabetes, cardiovascular diseases, and others, across the globe, are bolstering the growth of the market. This is attributed to the increased risk of organ failure among patients suffering from chronic diseases. According to the WHO, Cardiovascular diseases (CVDs) are the leading cause of death worldwide, taking approximately 17.9 million lives each year. Also, the geriatric population is more prone to organ malfunction, especially the liver, heart, and kidney, thus, in turn, driving the growth of the market. As per the United States Government Information on Organ Donation and Transplantation, in 2019, 63 % of those who had organ transplants were aged 50 or older, and 21% of overall organ transplant individuals were aged 65 and above.

Increasing Awareness and Increase in the Number of Organ Transplantation Surgeries

Over the past few years, people are becoming more aware of organ transplantation, which is augmenting the growth of the market. Owing to the awareness among the masses, people are going for organ transplantation surgeries, which is fueling the growth of the market. Various initiatives are taken by the government and non-government organizations to make people aware of organ transplantation. Moreover, the rise in number of organ transplantation surgeries is fueling the growth of the market. Owing to the increase in the number of patients with organ failure, the demand for transplant procedures is rising, which is facilitating the growth of the market. According to Health Resources and Services Administration, in 2019, about 112,568 people in the U.S. required organ transplantation.

Market Segmentation

The global organ transplant diagnostics market is segmented into component, transplant type, technology, application, end-user, and company. Based on components, the market is divided into kits & assays, consumables, and services. Based on transplant type, the market is divided into solid organ transplants and stem cell transplants. Based on technology, the market is segmented into molecular technologies, serology, flow cytometry, and others. Based on application, the market is divided into clinical diagnostics and translational research. Based on end-user, the market is divided into hospitals & transplant centers, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rise in the number of organ transplantation surgeries in the country.

Market Players

Illumina, Inc., Thermo Fischer Scientific, Inc., Abbott Laboratories, Inc., Quest Diagnostics, Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Laboratory Corporation of America Holdings, bioMerieux S.A., CareDx, Inc, and Immucor, Inc. are some of the leading companies operating in the market.

Report Scope

In this report, global organ transplant diagnostics market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Organ Transplant Diagnostics Market, By Component:

  • Kits & Assays
  • Consumables
  • Services

Organ Transplant Diagnostics Market, By Transplant Type:

  • Solid Organ Transplant
  • Stem Cell Transplant

Organ Transplant Diagnostics Market, By Technology:

  • Molecular Technologies
  • Serology
  • Flow Cytometry
  • Others

Organ Transplant Diagnostics Market, By Application:

  • Clinical Diagnostics
  • Translational Research

Organ Transplant Diagnostics Market, By End User:

  • Hospitals & Transplant Centers
  • Academic & Research Institutions
  • Others

Organ Transplant Diagnostics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Turkey
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Organ Transplant Diagnostics Market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Organ Transplant Diagnostics Market

5. Voice of Customer

6. Global Organ Transplant Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component (Kits & Assays, Consumables, Services)
    • 6.2.2. By Transplant Type (Solid Organ Transplant v/s Stem Cell Transplant)
    • 6.2.3. By Technology (Molecular Technologies, Serology, Flow Cytometry, Others)
    • 6.2.4. By Application (Clinical Diagnostics v/s Translational Research)
    • 6.2.5. By End User (Hospitals & Transplant Centers, Academic & Research Institutions, Others)
    • 6.2.6. By Company (2021)
    • 6.2.7. By Region
  • 6.3. Market Map

7. North America Organ Transplant Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component
    • 7.2.2. By Transplant Type
    • 7.2.3. By Technology
    • 7.2.4. By Application
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Organ Transplant Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
        • 7.3.1.2.2. By Transplant Type
        • 7.3.1.2.3. By Technology
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. Canada Organ Transplant Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
        • 7.3.2.2.2. By Transplant Type
        • 7.3.2.2.3. By Technology
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. Mexico Organ Transplant Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
        • 7.3.3.2.2. By Transplant Type
        • 7.3.3.2.3. By Technology
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User

8. Europe Organ Transplant Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component
    • 8.2.2. By Transplant Type
    • 8.2.3. By Technology
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Organ Transplant Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
        • 8.3.1.2.2. By Transplant Type
        • 8.3.1.2.3. By Technology
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. Germany Organ Transplant Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
        • 8.3.2.2.2. By Transplant Type
        • 8.3.2.2.3. By Technology
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. United Kingdom Organ Transplant Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
        • 8.3.3.2.2. By Transplant Type
        • 8.3.3.2.3. By Technology
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. Italy Organ Transplant Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
        • 8.3.4.2.2. By Transplant Type
        • 8.3.4.2.3. By Technology
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Spain Organ Transplant Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component
        • 8.3.5.2.2. By Transplant Type
        • 8.3.5.2.3. By Technology
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. Asia-Pacific Organ Transplant Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component
    • 9.2.2. By Transplant Type
    • 9.2.3. By Technology
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Organ Transplant Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
        • 9.3.1.2.2. By Transplant Type
        • 9.3.1.2.3. By Technology
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. India Organ Transplant Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
        • 9.3.2.2.2. By Transplant Type
        • 9.3.2.2.3. By Technology
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. Japan Organ Transplant Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component
        • 9.3.3.2.2. By Transplant Type
        • 9.3.3.2.3. By Technology
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User
    • 9.3.4. South Korea Organ Transplant Diagnostics Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Component
        • 9.3.4.2.2. By Transplant Type
        • 9.3.4.2.3. By Technology
        • 9.3.4.2.4. By Application
        • 9.3.4.2.5. By End User
    • 9.3.5. Australia Organ Transplant Diagnostics Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Component
        • 9.3.5.2.2. By Transplant Type
        • 9.3.5.2.3. By Technology
        • 9.3.5.2.4. By Application
        • 9.3.5.2.5. By End User

10. South America Organ Transplant Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component
    • 10.2.2. By Transplant Type
    • 10.2.3. By Technology
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Organ Transplant Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
        • 10.3.1.2.2. By Transplant Type
        • 10.3.1.2.3. By Technology
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Argentina Organ Transplant Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
        • 10.3.2.2.2. By Transplant Type
        • 10.3.2.2.3. By Technology
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. Colombia Organ Transplant Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component
        • 10.3.3.2.2. By Transplant Type
        • 10.3.3.2.3. By Technology
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. Middle East and Africa Organ Transplant Diagnostics Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Component
    • 11.2.2. By Transplant Type
    • 11.2.3. By Technology
    • 11.2.4. By Application
    • 11.2.5. By End User
    • 11.2.6. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Organ Transplant Diagnostics Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Component
        • 11.3.1.2.2. By Transplant Type
        • 11.3.1.2.3. By Technology
        • 11.3.1.2.4. By Application
        • 11.3.1.2.5. By End User
    • 11.3.2. Saudi Arabia Organ Transplant Diagnostics Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Component
        • 11.3.2.2.2. By Transplant Type
        • 11.3.2.2.3. By Technology
        • 11.3.2.2.4. By Application
        • 11.3.2.2.5. By End User
    • 11.3.3. UAE Organ Transplant Diagnostics Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Component
        • 11.3.3.2.2. By Transplant Type
        • 11.3.3.2.3. By Technology
        • 11.3.3.2.4. By Application
        • 11.3.3.2.5. By End User
    • 11.3.4. Turkey Organ Transplant Diagnostics Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Component
        • 11.3.4.2.2. By Transplant Type
        • 11.3.4.2.3. By Technology
        • 11.3.4.2.4. By Application
        • 11.3.4.2.5. By End User
    • 11.3.5. Egypt Organ Transplant Diagnostics Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Component
        • 11.3.5.2.2. By Transplant Type
        • 11.3.5.2.3. By Technology
        • 11.3.5.2.4. By Application
        • 11.3.5.2.5. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Illumina, Inc.
  • 14.2. Thermo Fischer Scientific, Inc.
  • 14.3. Abbott Laboratories, Inc.
  • 14.4. Quest Diagnostics, Inc.
  • 14.5. F. Hoffmann-La Roche AG
  • 14.6. Bio-Rad Laboratories, Inc.
  • 14.7. Laboratory Corporation of America Holdings
  • 14.8. bioMerieux S.A.
  • 14.9. CareDx, Inc
  • 14.10. Immucor, Inc.

15. Strategic Recommendations